PCSK9 Pleiotropism: In the Same Vein as Statins

Circ Res. 2022 Nov 11;131(11):890-892. doi: 10.1161/CIRCRESAHA.122.322035. Epub 2022 Nov 10.

Authors

Arick C Park¹, Xiangyu Zhang¹, Yu-Sheng Yeh¹, Babak Razani^{2

3}

Affiliations

¹ Cardiovascular Division, Department of Medicine, Washington University School of Medicine, St. Louis, MO (A.C.P., X.Z., Y.-S.Y.).
² Division of Cardiology and Vascular Medicine Institute, Department of Medicine, University of Pittsburgh School of Medicine and University of Pittsburgh Medical Center, Pittsburgh, PA (B.R.).
³ Pittsburgh VA Medical Center, Pittsburgh, PA (B.R.).

No abstract available

Keywords: Editorials; coronary artery disease; proprotein convertases; thrombosis; vascular grafting.

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Comment

MeSH terms

Hydroxymethylglutaryl-CoA Reductase Inhibitors* / pharmacology
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
Proprotein Convertase 9* / genetics
Proprotein Convertases
Serine Endopeptidases

Substances

PCSK9 protein, human
Proprotein Convertase 9
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Proprotein Convertases
Serine Endopeptidases

Grants and funding